203 related articles for article (PubMed ID: 19411629)
1. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.
Wei G; Srinivasan R; Cantemir-Stone CZ; Sharma SM; Santhanam R; Weinstein M; Muthusamy N; Man AK; Oshima RG; Leone G; Ostrowski MC
Blood; 2009 Jul; 114(5):1123-30. PubMed ID: 19411629
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction.
Wang L; Lin L; Qi H; Chen J; Grossfeld P
Circ Res; 2022 Aug; 131(5):371-387. PubMed ID: 35894043
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of ETS1 and ETS2 proteins in cancer.
Fry EA; Inoue K
Cancer Rep Rev; 2018; 2(3):. PubMed ID: 29974077
[TBL] [Abstract][Full Text] [Related]
4. The Ras activator RasGRP3 mediates diabetes-induced embryonic defects and affects endothelial cell migration.
Randhawa PK; Rylova S; Heinz JY; Kiser S; Fried JH; Dunworth WP; Anderson AL; Barber AT; Chappell JC; Roberts DM; Bautch VL
Circ Res; 2011 May; 108(10):1199-208. PubMed ID: 21474816
[TBL] [Abstract][Full Text] [Related]
5. A disease-associated gene desert directs macrophage inflammation through ETS2.
Stankey CT; Bourges C; Haag LM; Turner-Stokes T; Piedade AP; Palmer-Jones C; Papa I; Silva Dos Santos M; Zhang Q; Cameron AJ; Legrini A; Zhang T; Wood CS; New FN; Randzavola LO; Speidel L; Brown AC; Hall A; Saffioti F; Parkes EC; Edwards W; Direskeneli H; Grayson PC; Jiang L; Merkel PA; Saruhan-Direskeneli G; Sawalha AH; Tombetti E; Quaglia A; Thorburn D; Knight JC; Rochford AP; Murray CD; Divakar P; Green M; Nye E; MacRae JI; Jamieson NB; Skoglund P; Cader MZ; Wallace C; Thomas DC; Lee JC
Nature; 2024 Jun; 630(8016):447-456. PubMed ID: 38839969
[TBL] [Abstract][Full Text] [Related]
6. Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer.
Wallace JA; Li F; Balakrishnan S; Cantemir-Stone CZ; Pecot T; Martin C; Kladney RD; Sharma SM; Trimboli AJ; Fernandez SA; Yu L; Rosol TJ; Stromberg PC; Lesurf R; Hallett M; Park M; Leone G; Ostrowski MC
PLoS One; 2013; 8(8):e71533. PubMed ID: 23977064
[TBL] [Abstract][Full Text] [Related]
7. Pten in stromal fibroblasts suppresses mammary epithelial tumours.
Trimboli AJ; Cantemir-Stone CZ; Li F; Wallace JA; Merchant A; Creasap N; Thompson JC; Caserta E; Wang H; Chong JL; Naidu S; Wei G; Sharma SM; Stephens JA; Fernandez SA; Gurcan MN; Weinstein MB; Barsky SH; Yee L; Rosol TJ; Stromberg PC; Robinson ML; Pepin F; Hallett M; Park M; Ostrowski MC; Leone G
Nature; 2009 Oct; 461(7267):1084-91. PubMed ID: 19847259
[TBL] [Abstract][Full Text] [Related]
8. Review of Ets1 structure, function, and roles in immunity.
Garrett-Sinha LA
Cell Mol Life Sci; 2013 Sep; 70(18):3375-90. PubMed ID: 23288305
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.
John S; Russell L; Chin SS; Luo W; Oshima R; Garrett-Sinha LA
Mol Cell Biol; 2014 Feb; 34(3):522-32. PubMed ID: 24277931
[TBL] [Abstract][Full Text] [Related]
10. The role of the transcription factor Ets1 in carcinoma.
Dittmer J
Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377
[TBL] [Abstract][Full Text] [Related]
11. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.
Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573
[TBL] [Abstract][Full Text] [Related]
12. ETS-targeted therapy: can it substitute for MEK inhibitors?
Tetsu O; McCormick F
Clin Transl Med; 2017 Dec; 6(1):16. PubMed ID: 28474232
[TBL] [Abstract][Full Text] [Related]
13. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
14. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
15. Defective activation and survival of T cells lacking the Ets-1 transcription factor.
Muthusamy N; Barton K; Leiden JM
Nature; 1995 Oct; 377(6550):639-42. PubMed ID: 7566177
[TBL] [Abstract][Full Text] [Related]
16. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
Bories JC; Willerford DM; Grévin D; Davidson L; Camus A; Martin P; Stéhelin D; Alt FW
Nature; 1995 Oct; 377(6550):635-8. PubMed ID: 7566176
[TBL] [Abstract][Full Text] [Related]
17. Piezo1 (Piezo-Type Mechanosensitive Ion Channel Component 1)-Mediated Mechanosensation in Macrophages Impairs Perfusion Recovery After Hindlimb Ischemia in Mice.
Xie L; Wang X; Ma Y; Ma H; Shen J; Chen J; Wang Y; Su S; Chen K; Xu L; Xie Y; Xiang M
Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):504-518. PubMed ID: 36756881
[TBL] [Abstract][Full Text] [Related]
18. Chemerin regulates normal angiogenesis and hypoxia-driven neovascularization.
Ben Dhaou C; Mandi K; Frye M; Acheampong A; Radi A; De Becker B; Antoine M; Baeyens N; Wittamer V; Parmentier M
Angiogenesis; 2022 May; 25(2):159-179. PubMed ID: 34524600
[TBL] [Abstract][Full Text] [Related]
19. Heme Oxygenase-1 in Macrophages Impairs the Perfusion Recovery After Hindlimb Ischemia by Suppressing Autolysosome-Dependent Degradation of NLRP3.
Ma Y; Jia L; Wang Y; Ji Y; Chen J; Ma H; Lin X; Zhang Y; Li W; Ni H; Xie L; Xie Y; Xiang M
Arterioscler Thromb Vasc Biol; 2021 May; 41(5):1710-1723. PubMed ID: 33761761
[TBL] [Abstract][Full Text] [Related]
20. Heme Oxygenase-1 in Macrophages Drives Septic Cardiac Dysfunction via Suppressing Lysosomal Degradation of Inducible Nitric Oxide Synthase.
Jia L; Wang Y; Wang Y; Ma Y; Shen J; Fu Z; Wu Y; Su S; Zhang Y; Cai Z; Wang J; Xiang M
Circ Res; 2018 May; 122(11):1532-1544. PubMed ID: 29669713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
